Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Journal of Cancer Research and Clinical Oncology|February 16, 2017
Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin careCarl Christoph Schimanski, Frank Staib, Thomas Göhler, et al.
European Journal of Immunology|December 9, 2020
Antigen-driven PD-1+ TOX+ BHLHE40+ and PD-1+ TOX+ EOMES+ T lymphocytes regulate juvenile idiopathic arthritis in situPatrick Maschmeyer, Gitta Anne Heinz, Christopher Mark Skopnik, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 1, 2019
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantationMassimo Iavarone, Federica Invernizzi, Carolin Czauderna, et al.
Plos One|September 21, 2021
How COVID-19 kick-started online learning in medical education-The DigiMed studyFabian Stoehr, Lukas Müller, Adrian Brady, et al.
The Journal of Clinical Investigation|March 17, 2025
Activating antiviral immune responses potentiates immune checkpoint inhibition in glioblastoma modelsDeepa Seetharam, Jay Chandar, Christian K Ramsoomair, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Targeting ZNF638 activates antiviral immune responses and potentiates immune checkpoint inhibition in glioblastomaDeepa Seetharam, Jay Chandar, Christian K Ramsoomair, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 13, 2021
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective StudyMassimo Iavarone, Federica Invernizzi, Tommy Ivanics, et al.
Nature Communications|March 31, 2021
SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itselfMarta Ferreira-Gomes, Andrey Kruglov, Pawel Durek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2020
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysisÁlvaro Díaz-González, Marco Sanduzzi-Zamparelli, Leonardo G da Fonseca, et al.
Nature|March 13, 2025
TGFβ links EBV to multisystem inflammatory syndrome in childrenCarl Christoph Goetzke, Mona Massoud, Stefan Frischbutter, et al.
Pageof 14